Page last updated: 2024-10-26

diclofenac and Purpura, Thrombotic Thrombocytopenic

diclofenac has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research Excerpts

ExcerptRelevanceReference
"Diclofenac potassium is a non-steroidal anti-inflammatory drug that is used to treat pain."2.61Diclofenac-induced thrombotic thrombocytopenic purpura with concomitant complement dysregulation: a case report and review of the literature. ( Ali, A; Gaddam, M; Khaja, M; Lara, JP; Malik, S; Santana, Y, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lara, JP1
Santana, Y1
Gaddam, M1
Ali, A1
Malik, S1
Khaja, M1

Reviews

1 review available for diclofenac and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Diclofenac-induced thrombotic thrombocytopenic purpura with concomitant complement dysregulation: a case report and review of the literature.
    Journal of medical case reports, 2019, Jun-23, Volume: 13, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Complement System Proteins; Diclofenac; Drug Hyperse

2019